Message our hosts, Kieran and Jose.

In the second part of their discussion on mitral valve disease prognostic indicators, Jose and Kieran talk about what echo measurements provide the most useful assessment of prognosis in stage B disease, consider whether there is a place for using cardiac biomarkers in monitoring pre-clinical dogs, and review the recent literature covering how best to predict progression in pre-clinical dogs.